Vertex Pharmaceuticals Inc. appointed Carmen Bozic as its chief medical officer.
Bozic has been with the company as senior vice president and head of global clinical development since May, leading the development of Vertex's cystic fibrosis and alpha-1 antitrypsin deficiency programs.
She will assume the new position April 1, 2020, replacing Reshma Kewalramani, who will become Vertex's president and CEO.
Bozic previously spent more than 20 years at Biogen Inc., where she led multiple functions, including global clinical development, safety, preclinical safety, regulatory, clinical operations and biometrics.
